You just read:

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity

News provided by

Jazz Pharmaceuticals plc

10 Oct, 2019, 21:15 BST